An RTI activist TJ Abraham on Thursday alleged that the June 4 stampede during celebrations linked to the Royal Challengers Bengaluru (RCB) was “orchestrated and politically motivated,” resulting in ...

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of a new ...

Replacing some chemical pesticides with potentially safer, more environmentally benign alternatives is a significant ...

Royal Challenges Bengaluru vs Punjab Kings Live Telecast IPL 2025: RCB beat PBKS in Qualifier 1 last week to book their place in the final ...

Royal Enfield’s eagerly anticipated electric motorcycles, unveiled late last year under the Flying Flea brand, are now confirmed to hit the market early next year. Eicher Motors Managing ...

Portage Biotech presented new preclinical data for PORT-7 (TT-4) at the 2025 European Lung Cancer Congress in March. The new data demonstrate both single-agent activity for PORT-7 and a dramatic ...

Royal Bank of Canada reissued their outperform rating on shares of Legend Biotech (NASDAQ:LEGN – Free Report) in a report issued on Tuesday,Benzinga reports. The firm currently has a $84.00 ...

EXCLUSIVE: The hit USA Network series Royal Pains is getting a reboot at NBC with star Mark Feuerstein set to reprise the leading role of Dr. Henry “Hank” Lawson and will executive produce ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U.S., the report said.

Scotland’s role in advancing space biotech . Work towards advancing space biotech has already begun in Scotland, with the country leveraging its strong foundation in both biotechnology and space.

Biotech and drug stocks, collectively, are down an average of 16% over the past three months. The closely watched XBI index is down 19% in the same time period.

RBC Capital analyst Leonid Timashev maintained a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of $86.00. The company’s shares closed last Friday at $41.54 ...